Needham & Company reiterates a 'Buy' on Dendreon (DNDN); Why Wait? Early New Year Plans to Expand PROVENGE Marketing in the US Alongside Expanded Manufacturing Capacity
Tweet Send to a Friend
Needham & Company reiterates a 'Buy' on Dendreon (NASDAQ: DNDN), PT $62.
Needham analyst says, "We are encouraged by Dendreon’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "We are encouraged by Dendreon’s ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
